ID   EYA3_HUMAN              Reviewed;         573 AA.
AC   Q99504; A8K190; B4DIR7; B4DNZ7; O95463; Q8IVX7; Q99813;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   16-JUN-2009, sequence version 3.
DT   12-APR-2017, entry version 151.
DE   RecName: Full=Eyes absent homolog 3;
DE            EC=3.1.3.48 {ECO:0000269|PubMed:19234442, ECO:0000269|PubMed:19351884};
GN   Name=EYA3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RC   TISSUE=Embryo;
RX   PubMed=9020840; DOI=10.1038/ng0297-157;
RA   Abdelhak S., Kalatzis V., Heilig R., Compain S., Samson D.,
RA   Vincent C., Weil D., Cruaud C., Sahly I., Leibovici M.,
RA   Bitner-Glindzicz M., Francis M., Lacombe D., Vigneron J.,
RA   Charachon R., Boven K., Bedbeder P., van Regemorter N.,
RA   Weissenbach J., Petit C.;
RT   "A human homologue of the Drosophila eyes absent gene underlies
RT   branchio-oto-renal (BOR) syndrome and identifies a novel gene
RT   family.";
RL   Nat. Genet. 15:157-164(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Retina;
RX   PubMed=9049631; DOI=10.1101/gr.7.2.128;
RA   Zimmerman J.E., Bui Q.T., Steingrimsson E., Nagle D.L., Fu W.,
RA   Genin A., Spinner N.B., Copeland N.G., Jenkins N.A., Bucan M.,
RA   Bonini N.M.;
RT   "Cloning and characterization of two vertebrate homologs of the
RT   Drosophila eyes absent gene.";
RL   Genome Res. 7:128-141(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 4 AND 5).
RC   TISSUE=Brain, and Hippocampus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 413-531.
RX   PubMed=9887327; DOI=10.1093/hmg/8.1.11;
RA   Borsani G., DeGrandi A., Ballabio A., Bulfone A., Bernard L.,
RA   Banfi S., Gattuso C., Mariani M., Dixon M., Donnai D., Metcalfe K.,
RA   Winter R., Robertson M., Axton R., Brown A., van Heyningen V.,
RA   Hanson I.;
RT   "EYA4, a novel vertebrate gene related to Drosophila eyes absent.";
RL   Hum. Mol. Genet. 8:11-23(1999).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [10]
RP   FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=19351884; DOI=10.1074/jbc.C900032200;
RA   Krishnan N., Jeong D.G., Jung S.-K., Ryu S.E., Xiao A., Allis C.D.,
RA   Kim S.J., Tonks N.K.;
RT   "Dephosphorylation of the C-terminal tyrosyl residue of the DNA
RT   damage-related histone H2A.X is mediated by the protein phosphatase
RT   eyes absent.";
RL   J. Biol. Chem. 284:16066-16070(2009).
RN   [11]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, PHOSPHORYLATION AT
RP   SER-266, AND MUTAGENESIS OF SER-266 AND ASP-309.
RX   PubMed=19234442; DOI=10.1038/nature07849;
RA   Cook P.J., Ju B.G., Telese F., Wang X., Glass C.K., Rosenfeld M.G.;
RT   "Tyrosine dephosphorylation of H2AX modulates apoptosis and survival
RT   decisions.";
RL   Nature 458:591-596(2009).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-472, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-262 AND SER-438, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Tyrosine phosphatase that specifically dephosphorylates
CC       'Tyr-142' of histone H2AX (H2AXY142ph). 'Tyr-142' phosphorylation
CC       of histone H2AX plays a central role in DNA repair and acts as a
CC       mark that distinguishes between apoptotic and repair responses to
CC       genotoxic stress. Promotes efficient DNA repair by
CC       dephosphorylating H2AX, promoting the recruitment of DNA repair
CC       complexes containing MDC1 (PubMed:19234442, PubMed:19351884). Its
CC       function as histone phosphatase probably explains its role in
CC       transcription regulation during organogenesis. Coactivates SIX1,
CC       and seems to coactivate SIX2, SIX4 and SIX5. The repression of
CC       precursor cell proliferation in myoblasts by SIX1 is switched to
CC       activation through recruitment of EYA3 to the SIX1-DACH1 complex
CC       and seems to be dependent on EYA3 phosphatase activity (By
CC       similarity). May be involved in development of the eye.
CC       {ECO:0000250|UniProtKB:P97480, ECO:0000269|PubMed:19234442,
CC       ECO:0000269|PubMed:19351884}.
CC   -!- CATALYTIC ACTIVITY: Protein tyrosine phosphate + H(2)O = protein
CC       tyrosine + phosphate. {ECO:0000269|PubMed:19234442,
CC       ECO:0000269|PubMed:19351884}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:O00167};
CC       Note=Binds 1 Mg(2+) ion per subunit.
CC       {ECO:0000250|UniProtKB:O00167};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=1.8 uM for H2AXY142ph {ECO:0000269|PubMed:19351884};
CC         KM=72 uM for H2AXS139ph {ECO:0000269|PubMed:19351884};
CC   -!- SUBUNIT: Interacts with SIX1 and DACH1, and probably SIX2, SIX4,
CC       SIX5. {ECO:0000250|UniProtKB:P97480}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P97480}.
CC       Nucleus {ECO:0000269|PubMed:19234442}. Note=Localizes at sites of
CC       DNA damage at double-strand breaks (DSBs) (PubMed:19234442). With
CC       decreasing efficiency, translocalized to the nucleus by SIX2 and
CC       SIX5, and SIX4, respectively (By similarity).
CC       {ECO:0000250|UniProtKB:P97480, ECO:0000269|PubMed:19234442}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=Q99504-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q99504-2; Sequence=VSP_001493;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q99504-3; Sequence=VSP_054518, VSP_054519;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=Q99504-4; Sequence=VSP_054530;
CC         Note=No experimental confirmation available.;
CC       Name=5;
CC         IsoId=Q99504-5; Sequence=VSP_054518;
CC         Note=No experimental confirmation available.;
CC   -!- PTM: Ser-266 phosphorylation is required for localization at sites
CC       of DNA damage and directing interaction with H2AX.
CC       {ECO:0000269|PubMed:19234442}.
CC   -!- SIMILARITY: Belongs to the HAD-like hydrolase superfamily. EYA
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y10262; CAA71311.1; -; Genomic_DNA.
DR   EMBL; U81602; AAB42066.1; -; mRNA.
DR   EMBL; AK289805; BAF82494.1; -; mRNA.
DR   EMBL; AK295745; BAG58579.1; -; mRNA.
DR   EMBL; AK298129; BAG60409.1; -; mRNA.
DR   EMBL; AL512288; CAI14297.1; -; Genomic_DNA.
DR   EMBL; AL137792; CAI14297.1; JOINED; Genomic_DNA.
DR   EMBL; CH471059; EAX07713.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX07714.1; -; Genomic_DNA.
DR   EMBL; BC041667; AAH41667.1; -; mRNA.
DR   EMBL; AJ007991; CAA07814.1; -; mRNA.
DR   CCDS; CCDS316.1; -. [Q99504-1]
DR   CCDS; CCDS60050.1; -. [Q99504-4]
DR   CCDS; CCDS60051.1; -. [Q99504-5]
DR   CCDS; CCDS60052.1; -. [Q99504-3]
DR   RefSeq; NP_001269489.1; NM_001282560.1. [Q99504-3]
DR   RefSeq; NP_001269490.1; NM_001282561.1. [Q99504-5]
DR   RefSeq; NP_001269491.1; NM_001282562.1. [Q99504-4]
DR   RefSeq; NP_001981.2; NM_001990.3. [Q99504-1]
DR   UniGene; Hs.185774; -.
DR   ProteinModelPortal; Q99504; -.
DR   SMR; Q99504; -.
DR   BioGrid; 108441; 8.
DR   DIP; DIP-60448N; -.
DR   IntAct; Q99504; 2.
DR   STRING; 9606.ENSP00000362978; -.
DR   DEPOD; Q99504; -.
DR   iPTMnet; Q99504; -.
DR   PhosphoSitePlus; Q99504; -.
DR   BioMuta; EYA3; -.
DR   DMDM; 239938901; -.
DR   EPD; Q99504; -.
DR   MaxQB; Q99504; -.
DR   PaxDb; Q99504; -.
DR   PeptideAtlas; Q99504; -.
DR   PRIDE; Q99504; -.
DR   TopDownProteomics; Q99504-2; -. [Q99504-2]
DR   DNASU; 2140; -.
DR   Ensembl; ENST00000373863; ENSP00000362970; ENSG00000158161. [Q99504-3]
DR   Ensembl; ENST00000373871; ENSP00000362978; ENSG00000158161. [Q99504-1]
DR   Ensembl; ENST00000436342; ENSP00000405587; ENSG00000158161. [Q99504-4]
DR   Ensembl; ENST00000540618; ENSP00000442558; ENSG00000158161. [Q99504-5]
DR   GeneID; 2140; -.
DR   KEGG; hsa:2140; -.
DR   UCSC; uc001bpi.3; human. [Q99504-1]
DR   CTD; 2140; -.
DR   DisGeNET; 2140; -.
DR   GeneCards; EYA3; -.
DR   HGNC; HGNC:3521; EYA3.
DR   HPA; HPA052432; -.
DR   HPA; HPA062889; -.
DR   MIM; 601655; gene.
DR   neXtProt; NX_Q99504; -.
DR   OpenTargets; ENSG00000158161; -.
DR   PharmGKB; PA27933; -.
DR   eggNOG; ENOG410IR14; Eukaryota.
DR   eggNOG; ENOG410XQHR; LUCA.
DR   GeneTree; ENSGT00390000008860; -.
DR   HOGENOM; HOG000293149; -.
DR   HOVERGEN; HBG002447; -.
DR   InParanoid; Q99504; -.
DR   KO; K17621; -.
DR   OMA; SQYQACY; -.
DR   OrthoDB; EOG091G04YD; -.
DR   PhylomeDB; Q99504; -.
DR   TreeFam; TF319337; -.
DR   Reactome; R-HSA-5693565; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks.
DR   SABIO-RK; Q99504; -.
DR   SIGNOR; Q99504; -.
DR   ChiTaRS; EYA3; human.
DR   GenomeRNAi; 2140; -.
DR   PRO; PR:Q99504; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000158161; -.
DR   CleanEx; HS_EYA3; -.
DR   ExpressionAtlas; Q99504; baseline and differential.
DR   Genevisible; Q99504; HS.
DR   GO; GO:0005813; C:centrosome; IDA:HPA.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005667; C:transcription factor complex; IEA:InterPro.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0006302; P:double-strand break repair; IMP:UniProtKB.
DR   GO; GO:0016576; P:histone dephosphorylation; IDA:UniProtKB.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; IBA:GO_Central.
DR   GO; GO:0045739; P:positive regulation of DNA repair; IMP:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0010212; P:response to ionizing radiation; IDA:UniProtKB.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0007601; P:visual perception; TAS:ProtInc.
DR   Gene3D; 3.40.50.1000; -; 1.
DR   InterPro; IPR028479; EYA3.
DR   InterPro; IPR006545; EYA_dom.
DR   InterPro; IPR028472; EYA_fam.
DR   InterPro; IPR023214; HAD-like_dom.
DR   PANTHER; PTHR10190; PTHR10190; 1.
DR   PANTHER; PTHR10190:SF19; PTHR10190:SF19; 1.
DR   TIGRFAMs; TIGR01658; EYA-cons_domain; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Activator; Alternative splicing; Chromatin regulator;
KW   Complete proteome; Cytoplasm; Developmental protein; DNA damage;
KW   DNA repair; Hydrolase; Magnesium; Metal-binding; Nucleus;
KW   Phosphoprotein; Protein phosphatase; Reference proteome;
KW   Transcription; Transcription regulation.
FT   CHAIN         1    573       Eyes absent homolog 3.
FT                                /FTId=PRO_0000218648.
FT   ACT_SITE    309    309       Nucleophile. {ECO:0000305}.
FT   ACT_SITE    311    311       Proton donor.
FT                                {ECO:0000250|UniProtKB:O00167}.
FT   METAL       309    309       Magnesium.
FT                                {ECO:0000250|UniProtKB:O00167}.
FT   METAL       311    311       Magnesium; via carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:O00167}.
FT   METAL       537    537       Magnesium.
FT                                {ECO:0000250|UniProtKB:O00167}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:19413330}.
FT   MOD_RES     262    262       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     266    266       Phosphoserine.
FT                                {ECO:0000269|PubMed:19234442}.
FT   MOD_RES     438    438       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     472    472       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   VAR_SEQ       1    126       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:9049631}.
FT                                /FTId=VSP_001493.
FT   VAR_SEQ       1     53       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_054530.
FT   VAR_SEQ     121    166       Missing (in isoform 3 and isoform 5).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_054518.
FT   VAR_SEQ     548    572       HNMPFWRITNHGDLVSLHQALELDF -> QLYFLDMEALGC
FT                                QLEPTALILFIQLSGNLSNYNK (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_054519.
FT   MUTAGEN     266    266       S->A: Fails to form damage-dependent
FT                                nuclear foci or interact with H2AX.
FT                                {ECO:0000269|PubMed:19234442}.
FT   MUTAGEN     309    309       D->A: Loss of tyrosine phosphatase
FT                                activity toward H2AX.
FT                                {ECO:0000269|PubMed:19234442}.
FT   CONFLICT    105    105       Y -> D (in Ref. 1; CAA71311).
FT                                {ECO:0000305}.
FT   CONFLICT    142    142       H -> R (in Ref. 2; AAB42066).
FT                                {ECO:0000305}.
FT   CONFLICT    151    151       L -> V (in Ref. 2; AAB42066).
FT                                {ECO:0000305}.
FT   CONFLICT    253    253       R -> K (in Ref. 1; CAA71311).
FT                                {ECO:0000305}.
FT   CONFLICT    268    268       T -> S (in Ref. 2; AAB42066).
FT                                {ECO:0000305}.
FT   CONFLICT    283    283       T -> N (in Ref. 1; CAA71311).
FT                                {ECO:0000305}.
FT   CONFLICT    290    290       R -> K (in Ref. 1; CAA71311).
FT                                {ECO:0000305}.
FT   CONFLICT    305    305       V -> L (in Ref. 2; AAB42066).
FT                                {ECO:0000305}.
FT   CONFLICT    345    345       E -> K (in Ref. 1; CAA71311).
FT                                {ECO:0000305}.
FT   CONFLICT    357    357       F -> S (in Ref. 1; CAA71311).
FT                                {ECO:0000305}.
FT   CONFLICT    361    361       E -> K (in Ref. 1; CAA71311).
FT                                {ECO:0000305}.
FT   CONFLICT    373    381       SDDNGQDLS -> PNDKGQNLN (in Ref. 1;
FT                                CAA71311). {ECO:0000305}.
FT   CONFLICT    388    388       D -> N (in Ref. 1; CAA71311).
FT                                {ECO:0000305}.
FT   CONFLICT    447    449       RLR -> KLK (in Ref. 1; CAA71311).
FT                                {ECO:0000305}.
FT   CONFLICT    457    457       D -> N (in Ref. 1; CAA71311).
FT                                {ECO:0000305}.
FT   CONFLICT    473    473       R -> K (in Ref. 1; CAA71311).
FT                                {ECO:0000305}.
FT   CONFLICT    480    480       L -> P (in Ref. 2; AAB42066).
FT                                {ECO:0000305}.
FT   CONFLICT    487    487       V -> L (in Ref. 1; CAA71311).
FT                                {ECO:0000305}.
FT   CONFLICT    500    500       E -> K (in Ref. 1; CAA71311).
FT                                {ECO:0000305}.
FT   CONFLICT    524    526       SRF -> TSL (in Ref. 1; CAA71311).
FT                                {ECO:0000305}.
FT   CONFLICT    530    530       V -> L (in Ref. 1; CAA71311).
FT                                {ECO:0000305}.
SQ   SEQUENCE   573 AA;  62663 MW;  684B961B1E630371 CRC64;
     MEEEQDLPEQ PVKKAKMQES GEQTISQVSN PDVSDQKPET SSLASNLPMS EEIMTCTDYI
     PRSSNDYTSQ MYSAKPYAHI LSVPVSETAY PGQTQYQTLQ QTQPYAVYPQ ATQTYGLPPF
     GALWPGMKPE SGLIQTPSPS QHSVLTCTTG LTTSQPSPAH YSYPIQASST NASLISTSST
     IANIPAAAVA SISNQDYPTY TILGQNQYQA CYPSSSFGVT GQTNSDAEST TLAATTYQSE
     KPSVMAPAPA AQRLSSGDPS TSPSLSQTTP SKDTDDQSRK NMTSKNRGKR KADATSSQDS
     ELERVFLWDL DETIIIFHSL LTGSYAQKYG KDPTVVIGSG LTMEEMIFEV ADTHLFFNDL
     EECDQVHVED VASDDNGQDL SNYSFSTDGF SGSGGSGSHG SSVGVQGGVD WMRKLAFRYR
     KVREIYDKHK SNVGGLLSPQ RKEALQRLRA EIEVLTDSWL GTALKSLLLI QSRKNCVNVL
     ITTTQLVPAL AKVLLYGLGE IFPIENIYSA TKIGKESCFE RIVSRFGKKV TYVVIGDGRD
     EEIAAKQHNM PFWRITNHGD LVSLHQALEL DFL
//
